Latest Issue
PharmTech
Latest Issue
PharmTech Europe
| Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe | |||
|
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts. |
|||
|
Industry Briefs: Feb. 27, 2012
Company News Almac has acquired two pieces of encapsulation equipment for its North American headquarters in Souderton, Pennsylvania. Read More Angiochem and GlaxoSmithKline have formed a collaboration to discover, develop, and commercialize treatments for lysosomal storage diseases. Read More Auxilium Pharmaceuticals and Actelion Pharmaceuticals have formed a collaboration agreement for Xiaflex (collagenase clostridium histolyticum). Read More BASF has launched a white biotechnology and microbiology research laboratory at its Tarrytown, New York, facility. Read More Boehringer Ingelheim and Xencor have formed a collaboration agreement for the development, manufacture, and supply of biosuperior monoclonal antibodies. Read More EMD Millipore has partnered with Charles River Laboratories for viral-clearance studies. Read More In other news, EMD Millipore has opened its first laboratory water-production site in China. Read More Haupt Pharma and the Fraunhofer Institute optimize Haupt’s supply-chain capabilities. Read More Hospira has joined the Generic Pharmaceutical Association (GPhA). Read More Penn Pharma plans a £14-million ($22.2 million) investment in its South Wales, United Kingdom, facility to increase its global supply and its high-containment manufacturing capabilities. Read More Pfizer has acquired Alacer, a vitamin supplements company. Read More Roche has extended its tender offer for Illumina. Read More Sol-Gel has signed a $24.7-million agreement with an undisclosed pharmaceutical company for the development and commercialization in the United States and Canada of a dermatologic drug. Read More People News Amarillo Biosciences has appointed Stephen Chen as chairman and CEO. Joseph Cummins will remain as president and chief operating officer. Read More DPT Laboratories has named Kuljit Bhatia as vice-president of R&D. Read More Johnson & Johnson’s (J&J) board of directors has named Alex Gorsky to succeed Bill Weldon as CEO, effective Apr. 26, 2012. Gorsky was also nominated for election to the board of directors at J&J’s annual meeting of shareholders. Read More Mylan North America President Tony Mauro has been elected chairman of GPhA. Read More OSO BioPharmaceuticals has appointed Marian Meyer as director of laboratories. Read More
|
|
|||||||||||||||||||||||||